EviCure
1 known investors
Evicure is a biotech company developing cancer therapies based on extracellular vesicle (EV) subpopulations derived from stem cells, combining EV libraries with AI for production, therapeutics, and targeted drug delivery. Its first product, PL-Ex1, is an EV-based treatment for refractory non-small cell lung cancer (NSCLC).
Investors · 1
Frequently asked questions
- What does EviCure do?
- Evicure is a biotech company developing cancer therapies based on extracellular vesicle (EV) subpopulations derived from stem cells, combining EV libraries with AI for production, therapeutics, and targeted drug delivery. Its first product, PL-Ex1, is an EV-based treatment for refractory non-small cell lung cancer (NSCLC).
- Who are EviCure's investors?
- EviCure's investors include Peregrine Ventures.